[Form 4] Phibro Animal Health Corporation Insider Trading Activity
Daniel M. Bendheim, Executive Vice President, Corporate Strategy and a director of Phibro Animal Health Corporation (PAHC), reported a grant of 3,964 restricted stock units (RSUs) on 08/15/2025. The RSUs represent contingent rights to receive one share of Class A Common Stock per unit and were awarded at $0 purchase price. The RSUs vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to continued employment through each vesting date. The Form 4 was signed by an attorney-in-fact on 08/19/2025.
Daniel M. Bendheim, Vicepresidente esecutivo, Strategia aziendale e membro del consiglio di Phibro Animal Health Corporation (PAHC), ha riportato la concessione di 3,964 restricted stock units (RSU) in data 15/08/2025. Le RSU rappresentano il diritto condizionato a ricevere una azione di Classe A per unit脿 e sono state assegnate a un prezzo di acquisto di $0. Le RSU maturano in quote sostanzialmente uguali in ciascuno dei primi tre anniversari del 1 agosto 2025, subordinatamente al mantenimento dell'impiego fino a ciascuna data di maturazione. Il modulo Form 4 猫 stato firmato da un procuratore il 19/08/2025.
Daniel M. Bendheim, Vicepresidente Ejecutivo, Estrategia Corporativa y director de Phibro Animal Health Corporation (PAHC), report贸 la concesi贸n de 3,964 unidades restringidas de acciones (RSU) el 15/08/2025. Las RSU representan derechos contingentes para recibir una acci贸n Clase A por unidad y se otorgaron a un precio de compra de $0. Las RSU se consolidan en cuotas sustancialmente iguales en cada uno de los primeros tres aniversarios del 1 de agosto de 2025, sujetas a la continuidad del empleo hasta cada fecha de consolidaci贸n. El Formulario 4 fue firmado por un apoderado el 19/08/2025.
Daniel M. Bendheim, 旮办梾鞝勲灥 雼措嫻 靾橃劃攵�靷灔鞚挫瀽 Phibro Animal Health Corporation(PAHC) 鞚挫偓鞚� 攴鸽姅 2025-08-15鞐� 3,964臧滌潣 鞝滍暅攵� 欤检嫕 雼渼(RSU)毳� 攵�鞐皼鞎橂嫟瓿� 氤搓碃頄堨姷雼堧嫟. 頃措嫻 RSU電� 雼渼雼� 韥措灅鞀� A 氤错喌欤� 1欤茧ゼ 氚涭潉 靾� 鞛堧姅 臁瓣贝攵� 甓岆Μ毳� 鞚橂頃橂┌, $0鞚� 旆摑 臧�瓴╈溂搿� 靾橃棳霅橃棃鞀惦媹雼�. RSU電� 2025雲� 8鞗� 1鞚�鞚� 觳� 氩堨Ц 旮半厫鞚检潉 鞁滌瀾鞙茧 頄ロ泟 靹� 氩堨潣 旮半厫鞚� 臧侁皝鞐� 鞁れ鞝侅溂搿� 霃欖澕頃� 牍勳湪搿� 氩犾姢韺呺悩氅�, 臧� 氩犾姢韺呾澕 旯岇 瓿勳啀 攴茧頃橂姅 瓴冹澊 臁瓣贝鞛呺媹雼�. Form 4電� 2025-08-19鞐� 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟.
Daniel M. Bendheim, Vice鈥慞r茅sident Ex茅cutif, Strat茅gie d'entreprise et administrateur de Phibro Animal Health Corporation (PAHC), a d茅clar茅 une attribution de 3,964 unit茅s d'actions restreintes (RSU) le 15/08/2025. Les RSU repr茅sentent des droits conditionnels de recevoir une action de cat茅gorie A par unit茅 et ont 茅t茅 attribu茅es au prix d'achat de $0. Les RSU acquerront des droits par versements sensiblement 茅gaux 脿 chacun des trois premiers anniversaires du 1er ao没t 2025, sous r茅serve de la poursuite de l'emploi jusqu'脿 chaque date d'acquisition. Le formulaire Form 4 a 茅t茅 sign茅 par un mandataire le 19/08/2025.
Daniel M. Bendheim, Executive Vice President, Corporate Strategy und Direktor von Phibro Animal Health Corporation (PAHC), meldete die Gew盲hrung von 3,964 Restricted Stock Units (RSUs) am 15.08.2025. Die RSUs stellen bedingte Anspr眉che dar, pro Einheit eine Aktie der Klasse A zu erhalten, und wurden zu einem Kaufpreis von $0 gew盲hrt. Die RSUs werden in im Wesentlichen gleichen Raten an jedem der ersten drei Jahrestage des 1. August 2025 vesten, vorbehaltlich der fortgesetzten Besch盲ftigung bis zu jedem Vestingdatum. Das Formular Form 4 wurde am 19.08.2025 von einem Bevollm盲chtigten unterschrieben.
- Alignment with shareholders: RSUs vest over three years, aligning the executive's incentives with longer-term performance
- Retention tool: Grant structure (contingent RSUs) supports executive retention without immediate share issuance
- Potential future dilution: The RSUs convert to Class A shares upon vesting, which will increase outstanding shares over time
Insights
TL;DR: A mid-sized equity grant to an executive/director with standard multi-year vesting, indicating retention alignment without immediate dilution through sales.
The grant of 3,964 RSUs to a named executive who is also a director is a routine equity-based retention mechanism. Vesting over three annual installments beginning August 1, 2025 aligns the executive鈥檚 incentives with multi-year service to the company. The award price of $0 indicates these are typical restricted stock units rather than a purchased award. There is no evidence in this filing of exercised options, dispositions, or sales that would change immediate share count.
TL;DR: The Form 4 discloses a grant, not a market transaction; the filing conveys limited near-term market impact.
The reported transaction code and details show an acquisition (grant) of RSUs, not a cash purchase or sale. Because vesting is contingent and spread over three years, the award does not represent immediate issuance of shares to the reporting person. The filing contains no pricing for underlying stock sales or exercises and therefore implies no short-term change to outstanding free-floating shares from this reporting alone.
Daniel M. Bendheim, Vicepresidente esecutivo, Strategia aziendale e membro del consiglio di Phibro Animal Health Corporation (PAHC), ha riportato la concessione di 3,964 restricted stock units (RSU) in data 15/08/2025. Le RSU rappresentano il diritto condizionato a ricevere una azione di Classe A per unit脿 e sono state assegnate a un prezzo di acquisto di $0. Le RSU maturano in quote sostanzialmente uguali in ciascuno dei primi tre anniversari del 1 agosto 2025, subordinatamente al mantenimento dell'impiego fino a ciascuna data di maturazione. Il modulo Form 4 猫 stato firmato da un procuratore il 19/08/2025.
Daniel M. Bendheim, Vicepresidente Ejecutivo, Estrategia Corporativa y director de Phibro Animal Health Corporation (PAHC), report贸 la concesi贸n de 3,964 unidades restringidas de acciones (RSU) el 15/08/2025. Las RSU representan derechos contingentes para recibir una acci贸n Clase A por unidad y se otorgaron a un precio de compra de $0. Las RSU se consolidan en cuotas sustancialmente iguales en cada uno de los primeros tres aniversarios del 1 de agosto de 2025, sujetas a la continuidad del empleo hasta cada fecha de consolidaci贸n. El Formulario 4 fue firmado por un apoderado el 19/08/2025.
Daniel M. Bendheim, 旮办梾鞝勲灥 雼措嫻 靾橃劃攵�靷灔鞚挫瀽 Phibro Animal Health Corporation(PAHC) 鞚挫偓鞚� 攴鸽姅 2025-08-15鞐� 3,964臧滌潣 鞝滍暅攵� 欤检嫕 雼渼(RSU)毳� 攵�鞐皼鞎橂嫟瓿� 氤搓碃頄堨姷雼堧嫟. 頃措嫻 RSU電� 雼渼雼� 韥措灅鞀� A 氤错喌欤� 1欤茧ゼ 氚涭潉 靾� 鞛堧姅 臁瓣贝攵� 甓岆Μ毳� 鞚橂頃橂┌, $0鞚� 旆摑 臧�瓴╈溂搿� 靾橃棳霅橃棃鞀惦媹雼�. RSU電� 2025雲� 8鞗� 1鞚�鞚� 觳� 氩堨Ц 旮半厫鞚检潉 鞁滌瀾鞙茧 頄ロ泟 靹� 氩堨潣 旮半厫鞚� 臧侁皝鞐� 鞁れ鞝侅溂搿� 霃欖澕頃� 牍勳湪搿� 氩犾姢韺呺悩氅�, 臧� 氩犾姢韺呾澕 旯岇 瓿勳啀 攴茧頃橂姅 瓴冹澊 臁瓣贝鞛呺媹雼�. Form 4電� 2025-08-19鞐� 雽�毽澑鞚� 靹滊獏頄堨姷雼堧嫟.
Daniel M. Bendheim, Vice鈥慞r茅sident Ex茅cutif, Strat茅gie d'entreprise et administrateur de Phibro Animal Health Corporation (PAHC), a d茅clar茅 une attribution de 3,964 unit茅s d'actions restreintes (RSU) le 15/08/2025. Les RSU repr茅sentent des droits conditionnels de recevoir une action de cat茅gorie A par unit茅 et ont 茅t茅 attribu茅es au prix d'achat de $0. Les RSU acquerront des droits par versements sensiblement 茅gaux 脿 chacun des trois premiers anniversaires du 1er ao没t 2025, sous r茅serve de la poursuite de l'emploi jusqu'脿 chaque date d'acquisition. Le formulaire Form 4 a 茅t茅 sign茅 par un mandataire le 19/08/2025.
Daniel M. Bendheim, Executive Vice President, Corporate Strategy und Direktor von Phibro Animal Health Corporation (PAHC), meldete die Gew盲hrung von 3,964 Restricted Stock Units (RSUs) am 15.08.2025. Die RSUs stellen bedingte Anspr眉che dar, pro Einheit eine Aktie der Klasse A zu erhalten, und wurden zu einem Kaufpreis von $0 gew盲hrt. Die RSUs werden in im Wesentlichen gleichen Raten an jedem der ersten drei Jahrestage des 1. August 2025 vesten, vorbehaltlich der fortgesetzten Besch盲ftigung bis zu jedem Vestingdatum. Das Formular Form 4 wurde am 19.08.2025 von einem Bevollm盲chtigten unterschrieben.
FAQ
What did PAHC insider Daniel Bendheim report on Form 4?
When do the RSUs granted to Daniel Bendheim vest?
Did the Form 4 show a purchase price for the RSUs?
What roles does the reporting person hold at PAHC?
Was there an immediate sale or exercise reported in this filing?
